Expression of human telomerase subunits in ovarian malignant borderline and benign tumors

被引:1
|
作者
Kyo, S
Kanaya, T
Takakura, M
Tanaka, M
Yamashita, A
Inoue, H
Inoue, M
机构
[1] Kanazawa Univ, Sch Med, Dept Obstet & Gynecol, Kanazawa, Ishikawa 9208641, Japan
[2] Osaka Univ, Microbial Dis Res Inst, Dept Tumor Virol, Osaka, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Telomerase activity is involved in the maintenance of telomere length and is thought to be required for cellular immortality and oncogenesis. Three major subunits composing telomerase, human telomerase RNA (hTR), telomerase-associated protein (TPI) and human telomerase catalytic subunit (hTERT), have been identified. However, their functions and the regulatory mechanisms by which telomerase is activated have not been fully determined. In the present study, a total of 35 epithelial ovarian cancers, 5 ovarian low potential malignancies (LPM), 11 ovarian benign cysts and 12 normal ovaries, as well as various cell lines derived from ovarian cancers, were examined for the expression of hTR, TPI mRNA and hTERT mRNA. Correlations of expression with telomerase activity were evaluated. Reverse transcription-polymerase chain reaction (RT-PCR) analysis revealed that hTR and TPI mRNA were expressed in more than 80% of ovarian cancers, LPM, ovarian cysts and even in normal ovaries. However, hTERT mRNA was observed only in ovarian cancers, most of which exhibited telomerase activity. Normal ovarian tissues, ovarian cysts and LPM, most of which had no telomerase activity, did not express hTERT. Five telomerase-positive ovarian cancer cell lines expressed each of the telomerase subunits, whereas 2 telomerase-negative normal primary fibroblast cell lines expressed TPI mRNA and hTR, but not hTERT mRNA, There was a significant correlation of telomerase activity with hTERT mRNA expression but not with TPI or hTR expression. Expression of hTERT is thus specific to cancer lesions and appears to be a rate-limiting determinant of the enzymatic activity of human telomerase. Up-regulation of hTERT may play a critically important role in the development of ovarian cancers. Int. J. Cancer 80:804-809, 1999. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:804 / 809
页数:6
相关论文
共 50 条
  • [1] BORDERLINE OVARIAN TUMORS - ARE THEY BENIGN OR MALIGNANT?
    Lazarou, Anastasia
    Fotopoulou, Christina
    Coumbos, Alexandra
    Sehouli, Jalid
    Vasiljeva, Jekaterina
    Braicu, Ioana
    Burger, Heinz
    Kuehn, Wolfgang
    [J]. ANTICANCER RESEARCH, 2014, 34 (10) : 6257 - 6257
  • [2] Telomerase activation and expression of its catalytic subunits in benign and malignant tumors of the parathyroid
    Onoda, N
    Ogisawa, K
    Ishikawa, T
    Takenaka, C
    Tahara, H
    Inaba, M
    Takashima, T
    Hirakawa, K
    [J]. SURGERY TODAY, 2004, 34 (05) : 389 - 393
  • [3] Telomerase Activation and Expression of its Catalytic Subunits in Benign and Malignant Tumors of the Parathyroid
    Naoyoshi Onoda
    Kana Ogisawa
    Tetsuro Ishikawa
    Chiemi Takenaka
    Hideki Tahara
    Masaaki Inaba
    Tsutomu Takashima
    Kosei Hirakawa
    [J]. Surgery Today, 2004, 34 : 389 - 393
  • [4] u-PA expression in benign, borderline and malignant ovarian tumors
    Kiziridou, AD
    Toliou, T
    Stefanou, D
    Agnantis, N
    [J]. ANTICANCER RESEARCH, 2002, 22 (2A) : 985 - 990
  • [5] Telomerase activity in benign and malignant epithelial ovarian tumors
    Wan, MH
    Li, WZ
    Duggan, BD
    Felix, JC
    Zhao, YL
    Dubeau, L
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (06) : 437 - 441
  • [6] Phenotypic analysis of ovarian carcinoma: Polypeptide expression in benign, borderline and malignant tumors
    Alaiya, AA
    Franzen, B
    Fujioka, K
    Moberger, B
    Schedvins, K
    Silversvard, C
    Linder, S
    Auer, G
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1997, 73 (05) : 678 - 683
  • [7] Comparison of benign, borderline, and malignant mucinous ovarian tumors
    Yamamoto, Y.
    Kunimi, Y.
    Wakikawa, A.
    Ueno, A.
    Nagai, R.
    Komatsu, J.
    Minami, S.
    Hayashi, K.
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2018, 39 (05) : 751 - 754
  • [8] Methylation profile in benign, borderline and malignant ovarian tumors
    K. F. Tam
    V. W. S. Liu
    S. S. Liu
    P. C. K. Tsang
    A. N. Y. Cheung
    A. M. W. Yip
    H. Y. S. Ngan
    [J]. Journal of Cancer Research and Clinical Oncology, 2007, 133 : 331 - 341
  • [9] Methylation profile in benign, borderline and malignant ovarian tumors
    Tam, K. F.
    Liu, V. W. S.
    Liu, S. S.
    Tsang, P. C. K.
    Cheung, A. N. Y.
    Yip, A. M. W.
    Ngan, H. Y. S.
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2007, 133 (05) : 331 - 341
  • [10] Differential Nuclear Expression of Aurora A Kinase in Benign, Borderline, and Malignant Serous Ovarian Tumors
    Cratte, J. E.
    Sehultz, D. S.
    Inamdar, K. V.
    Lehman, N. L.
    [J]. MODERN PATHOLOGY, 2010, 23 : 238A - 238A